Effect of melatonin on subjective sleep quality in patients with chronic obstructive pulmonary disease

Not Applicable

• Conditions: COPD.; Other specified chronic obstructive pulmonary disease

• Registration Number: IRCT201110237872N1
• Lead Sponsor: Shahid Sadoughi University of Medical Sciences and Health Services

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 54

Inclusion Criteria

Inclusion criteria :COPD patients in stage 2-4 according to GOLD criteria with poor sleep quality (sleep quality more than 5 according to Pittsburgh Sleep Quality Index (PSQI))
Excusion criteria : history of COPD exacerbation during to previous 4 weeks , obstructive sleep apnea, mental disorder, or hypnotic-sedative medication, nocturnal oxygen therapy, and shift work

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sleep quality. Timepoint: at the first of the study and one month after the treatment. Method of measurement: According to the Pittsburgh Sleep Quality Index, PSQI.

Secondary Outcome Measures

Name	Time	Method
Oxygenation. Timepoint: at the first of the study and one month after treatment1 month. Method of measurement: pulse oximeter.;Daily sleepness. Timepoint: at the first of the study and one month after treatment1 month. Method of measurement: on basis of ESS (Epworth Sleepiness scale).;Pulmonary function test. Timepoint: at the first of the study and one month after treatment1 month. Method of measurement: FEV1 ,FVC,FEV1/FVC and FEF25-75.